Waldencast plc (NASDAQ: WALD) will hold its 2026 Annual General Meeting on 4 August 2026 in London, with a record date of 26 June 2026. Following the sale of Obagi Medical, directors Michel Brousset and Hind Sebti will resign, and Mazdack Rassi will be appointed to the Board as a Class II director effective at the meeting. Waldencast plc is a beauty brand parent company focusing on Milk Makeup.